Hayley Mark1, Lisa Gilbert, Joy Nanda. 1. Department of Community-Public Health, Johns Hopkins University, School of Nursing, 525 North Wolfe Street, Room 449 Baltimore, MD 21205-2110, USA. hmark1@son.jhmi.edu
Abstract
OBJECTIVE: To assess the psychosocial well-being and quality of life among women with a new genital herpes simplex virus diagnosis. DESIGN: Data were collected by a cross-sectional survey. PARTICIPANTS: Eighty-three women diagnosed with genital herpes simplex virus by culture, visual exam and/or a description of symptoms within the last 3 months were recruited from primary health care clinics by their provider. MEASURES: Participants completed the Hospital Anxiety and Depression Scale and the Recurrent Genital Herpes Quality of Life scale. RESULTS: Thirty-four percent of the women qualified as "clinical cases" for depression, and 64% were designated as "anxiety cases" based on Hospital Anxiety and Depression Scale scoring methods. A majority of participants reported feeling ashamed about having herpes and worried about having an outbreak or giving herpes to someone else. CONCLUSIONS: Despite substantial progress toward understanding genital herpes simplex virus epidemiology and transmission, a diagnosis of genital herpes continues to cause considerable psychosocial morbidity and to impact quality of life. There is a dearth of good evidence on how best to intervene to minimize the psychological impact of a diagnosis. Experts recommend addressing both the medical and psychological aspects of infection by providing antiviral therapy, written material, and resources.
OBJECTIVE: To assess the psychosocial well-being and quality of life among women with a new genital herpes simplex virus diagnosis. DESIGN: Data were collected by a cross-sectional survey. PARTICIPANTS: Eighty-three women diagnosed with genital herpes simplex virus by culture, visual exam and/or a description of symptoms within the last 3 months were recruited from primary health care clinics by their provider. MEASURES: Participants completed the Hospital Anxiety and Depression Scale and the Recurrent Genital Herpes Quality of Life scale. RESULTS: Thirty-four percent of the women qualified as "clinical cases" for depression, and 64% were designated as "anxiety cases" based on Hospital Anxiety and Depression Scale scoring methods. A majority of participants reported feeling ashamed about having herpes and worried about having an outbreak or giving herpes to someone else. CONCLUSIONS: Despite substantial progress toward understanding genital herpes simplex virus epidemiology and transmission, a diagnosis of genital herpes continues to cause considerable psychosocial morbidity and to impact quality of life. There is a dearth of good evidence on how best to intervene to minimize the psychological impact of a diagnosis. Experts recommend addressing both the medical and psychological aspects of infection by providing antiviral therapy, written material, and resources.
Authors: S Asgari; L Chamani-Tabriz; S Asadi; F Fatemi; H Zeraati; M M Akhondi; A Shahnazi Journal: Iran Red Crescent Med J Date: 2011-11-01 Impact factor: 0.611
Authors: Supriya D Mehta; Rachel K Nordgren; Walter Agingu; Fredrick Otieno; Winnie Odongo; Finch Odhiambo; Robert C Bailey Journal: J Sex Med Date: 2018-09-12 Impact factor: 3.802
Authors: Ian H Spicknall; Katharine J Looker; Sami L Gottlieb; Harrell W Chesson; Joshua T Schiffer; Jocelyn Elmes; Marie-Claude Boily Journal: Vaccine Date: 2018-04-04 Impact factor: 3.641